ResearcherGentofte HospitalNo recent work listed

Inna Chen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 5 (principal investigator on 5)
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2016: 2 trials · 2017: 1 trial · 2018: none · 2019: none · 2020: 1 trial · 2021: 1 trial

Trials 5

Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) Principal investigator NCT04611867 ↗
Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer. Principal investigator NCT04247165 ↗
Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients Principal investigator NCT02767557 ↗
Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer Principal investigator NCT02767752 ↗
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients Principal investigator NCT02866383 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Olav Faisal Dajani · 1 shared trial, 2017 · strength 0.22
- Trial Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients NCT02767557 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.